The TRanslational Initiative to ​DErisk NeuroTherapeutic (TRIDENT) draws upon research supported by the Government of Canada’s New Frontiers in Research Fund (NFRF).
 

Le TRanslational Initiative to ​DErisk NeuroTherapeutic (TRIDENT) repose sur des recherches financées par le fonds Nouvelles frontières en recherche dugouvernement du Canada.

By offering a transformative approach to preclinical evaluation of neurotherapeutics, TRIDENT will dramatically improve the odds of success of  neurotherapeutics in clinical trials for the benefit of humans across the globe.